BRAF and thyroid tumor: However, it has been shown that thyroid tumor cells, characterized by a constitutive activation of the MAPK pathway (due to the mutations of oncogenes such as RAS, BRAF, and RET/PTC), are more susceptible to NK cell-mediated killing.